4//SEC Filing
HUFF CURTIS W 4
Accession 0000950170-24-001385
CIK 0001907685other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 8:09 PM ET
Size
13.2 KB
Accession
0000950170-24-001385
Insider Transaction Report
Form 4
Freebird Partners LP
10% Owner
Transactions
- Purchase
Common Stock Purchase Warrant
2023-12-29+4,907,272→ 7,362,005 totalExercise: $0.06From: 2023-12-29Exp: 2028-12-29→ Common Stock, par value $0.0001 per share (4,907,272 underlying) - Purchase
Convertible Note Shares
2023-12-29$0.06/sh+2,453,636$134,950→ 2,453,636 totalExercise: $0.06From: 2023-12-29Exp: 2024-12-29→ Common Stock, par value $0.0001 per share (2,453,636 underlying)
Freebird Investments LLC
10% Owner
Transactions
- Purchase
Convertible Note Shares
2023-12-29$0.06/sh+2,453,636$134,950→ 2,453,636 totalExercise: $0.06From: 2023-12-29Exp: 2024-12-29→ Common Stock, par value $0.0001 per share (2,453,636 underlying) - Purchase
Common Stock Purchase Warrant
2023-12-29+4,907,272→ 7,362,005 totalExercise: $0.06From: 2023-12-29Exp: 2028-12-29→ Common Stock, par value $0.0001 per share (4,907,272 underlying)
HUFF CURTIS W
10% Owner
Transactions
- Purchase
Convertible Note Shares
2023-12-29$0.06/sh+2,453,636$134,950→ 2,453,636 totalExercise: $0.06From: 2023-12-29Exp: 2024-12-29→ Common Stock, par value $0.0001 per share (2,453,636 underlying) - Purchase
Common Stock Purchase Warrant
2023-12-29+4,907,272→ 7,362,005 totalExercise: $0.06From: 2023-12-29Exp: 2028-12-29→ Common Stock, par value $0.0001 per share (4,907,272 underlying)
Footnotes (3)
- [F1]This report is filed jointly by Freebird Partners LP, a Texas limited partnership ("Freebird Partners"), Freebird Investments LLC, a Texas limited liability company ("Freebird Investments"), and Curtis W. Huff (each a "Reporting Person" and collectively, the "Reporting Persons") in connection with their respective direct and indirect ownership of common stock, par value $0.0001 ("Common Stock") of Comera Life Sciences Holdings, Inc. (the "Company"). These securities of the Company are held of record by Freebird Partners. Freebird Investments serves as the general partner of Freebird Partners. Curtis W. Huff is the sole member of Freebird Investments. By virtue of these relationships, each of Freebird Investments and Mr. Huff may be deemed to share beneficial ownership of the securities held of record by Freebird Partners.
- [F2]Pursuant to that certain Securities Purchase Agreement dated December 29, 2023, as announced in the Issuer's Current Report on Form 8-K filed with the Securities Exchange Commission on December 29, 2023, Freebird Partners agreed to purchase, and the Company agreed to sell, for an aggregate purchase price of $134,950, (i) a Senior Convertible Note in the principal amount of $134,950 (the "Note") with a one (1) year term, and (ii) a warrant to purchase up to 4,907,272 shares of Common Stock (the "Warrant" and such transactions the "Transactions").
- [F3](Continued from footnote 2) The Note may be converted at any time and from time to time after December 29, 2023, at the option of the holder, at a conversion price of $0.055 per share of Common Stock, to the extent that after giving effect to such conversion the Reporting Persons and their affiliates would beneficially own no more than 9.99% of the outstanding shares of Common Stock of the Company. The Warrant became exercisable on December 29, 2023, and may be exercised through December 29, 2028, at an exercise price of $0.055 per share of Common Stock, to the extent that after giving effect to such exercise the Reporting Persons and their affiliates would beneficially own no more than 9.99% of the outstanding shares of Common Stock of the Company.
Documents
Issuer
Comera Life Sciences Holdings, Inc.
CIK 0001907685
Entity typeother
Related Parties
1- filerCIK 0001250127
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 8:09 PM ET
- Size
- 13.2 KB